Adding More Precision to Precision Oncology by Proteomics

29 Jan 2026
Proteogenomics & Translational Omics Stage
  • Almost all cancers are driven by malfunctioning proteins and the signaling networks they act in. 

  • Almost all cancer drugs act on proteins, are proteins or degrade proteins. 

  • Therefore, it makes sense to study cancer and the drugs to treat it at the level of the proteome 

Speakers
Bernhard Küster
Bernhard Küster, Chair of Proteomics and Bioanalytics - Technical University of Munich